The United States of Generics

from Off Script: A Pharma Manufacturing Podcast · host Pharma Manufacturing

Should America reshore more generic drug manufacturing? Will it really keep our supply chains safe from disruptions? For our September cover story, we took a deep dive into these questions to untangle the arguments around reshoring generic drug production. Find out why we walked away so obsessed with Rosemary Gibson and why Phlow Corp. might be the company that settles the debate around reshoring once and for all.

Episode metadata supplied by the publisher feed · Published Oct 5, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

The United States of Generics

0:00 19:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Off Script: A Pharma Manufacturing Podcast?

This episode is 19 minutes long.

When was this Off Script: A Pharma Manufacturing Podcast episode published?

This episode was published on October 5, 2020.

Can I download this Off Script: A Pharma Manufacturing Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!